ISSN: 0720-9355

Journal Home

Journal Guideline

Hamostaseologie Q2 Unclaimed

Georg Thieme Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hamostaseologie is a journal indexed in SJR in Hematology with an H index of 39. It has an SJR impact factor of 0,594 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,594.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,594

SJR Impact factor

39

H Index

68

Total Docs (Last Year)

205

Total Docs (3 years)

2249

Total Refs

365

Total Cites (3 years)

171

Citable Docs (3 years)

1.44

Cites/Doc (2 years)

33.07

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Thrombosis Research Q2
Cancer Control Q2
Annals of Hematology Q2
Platelets Q2
Transfusion Medicine Reviews Q2

Compare this journals

Aims and Scope

Best articles by citations

Acute Transmural Myocardial Infarction by Coronary Embolism in a Patient with JAK2 V617F-Positive Essential Thrombocythemia

End-stage renal disease and thrombophilia

Anticoagulants

Risks and challenges of orthopaedic invasive interventions in haemo -philia in a low-resource country

Erworbenes von-Willebrand-Syndrom Typ 2A als Begleiterscheinung eines Dialyseshunts?

Targeting platelet receptors in thrombotic and thrombo-inflammatory disorders

Anticoagulation in patients with impaired renal function and with haemodialysis

Altersabhängige Ansteuerung der Muskulatur im Stand bei Patienten mit Hämophilie

Platelet-derived chemokines in atherosclerosis

Management of bleeding with oral anticoagulants in patients with atrial fibrillation

Immune Thrombocytopenia - A Disease or a Group of Disorders? Where Do We Stand in 2019?

Pain therapy in haemophilia in Germany

SHOW MORE ARTICLES

Key transcriptional regulators of the vasoprotective effects of shear stress

Phospholipid inhibitors

Anwendungen des endogenen Thrombinpotenzials

Repeated Administration of Idarucizumab to a Patient with Dabigatran Overdose

Monocyte subsets in atherosclerosis

Neue Ansätze und Indikationen zur Plättchenfunktionsdiagnostik in der Kardiologie

Ergebnis der Leserumfrage zur Zeitschrift Hämostaseologie

The impact of bleeding disorders on the socioeconomic status of adult patients

Lebensmittelkonsum und Ernährungs-verhalten bei Patienten mit Hämophilie vor und nach Ernährungsberatung

Clinical pearls: Laboratory assessments of direct oral anticoagulants (DOACS)

Elective total knee arthroplasty in haemophilic patients

MRI, the technology for imaging of thrombi and inflammation